C12N 2760/16063
By chemical treatment
Official title: by chemical treatment
C12N2760/16063 (By chemical treatment) appears on 6 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 6
- Assignees
- 8
- Inventors
- 16
- Latest grant
- 13 Nov 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Alkylated influenza vaccines13 Nov 2018US 10,124,056 B2Sanofi Pasteur Limited
- Antiviral agent24 Jan 2017US 9,549,949 B2Nbc Meshtec Inc.
- Organic peroxide compounds for microorganism inactivation30 Aug 2016US 9,426,989 B2Novartis AG
- Method of inactivating lipid-enveloped viruses24 Oct 2000US 6,136,321 ABaxter Aktiengesellschaft
- Methods for the selective modification of viral nucleic acids24 Oct 2000US 6,136,586 AV. I. Technologies, Inc.
- A vaccine for coronavirus and influenza virus, and method for preparation thereof5 Dec 2024US 2024/0398930 A1Bharat Biotech International Limited
- Antiviral agent30 Mar 2017US 2017/0086463 A1Nbc Meshtec Inc.
- Alkylated influenza vaccines18 Feb 2016US 2016/0045590 A1Sanofi Pasteur Biologics, LLC
- Organic peroxide compounds for microorganism inactivation13 Jun 2013US 2013/0149194 A1Novartis AG
- Antiviral agent11 Aug 2011US 2011/0195108 A1Nbc Meshtec Inc.
Most cited
By later US patents
- Vaccines and methods for their production50US 5,698,432 ARetroscreen Ltd. · 1997
- Methods for the selective modification of viral nucleic acids40US 6,136,586 AV. I. Technologies, Inc. · 2000
- Method of inactivating lipid-enveloped viruses32US 6,136,321 ABaxter Aktiengesellschaft · 2000
- Antiviral agent2US 9,549,949 B2Nbc Meshtec Inc. · 2017
- Alkylated influenza vaccines1US 10,124,056 B2Sanofi Pasteur Limited · 2018